Literature DB >> 33406403

The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies.

Daqian Xu1, Fei Shao2, Xueli Bian2, Ying Meng1, Tingbo Liang1, Zhimin Lu3.   

Abstract

Key pathological, including oncogenic, signaling pathways regulate the canonical functions of metabolic enzymes that serve the cellular metabolic needs. Importantly, these signaling pathways also confer a large number of metabolic enzymes to have noncanonical or nonmetabolic functions that are referred to as "moonlighting" functions. In this review, we highlight how aberrantly regulated metabolic enzymes with such activities play critical roles in the governing of a wide spectrum of instrumental cellular activities, including gene expression, cell-cycle progression, DNA repair, cell proliferation, survival, apoptosis, and tumor microenvironment remodeling, thereby promoting the pathologic progression of disease, including cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA repair; apoptosis; cell proliferation; cell-cycle progression; gene expression; metabolic enzyme; noncanonical function; survival; tumor microenvironment

Year:  2021        PMID: 33406403     DOI: 10.1016/j.cmet.2020.12.015

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  18 in total

1.  Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma.

Authors:  Fei Shao; Xueli Bian; Juhong Wang; Daqian Xu; Wei Guo; Hongfei Jiang; Gaoxiang Zhao; Lei Zhu; Shuai Wang; Dongming Xing; Yibo Gao; Jie He; Zhimin Lu
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

2.  Fructose-1,6-bisphosphatase 1 functions as a protein phosphatase to dephosphorylate histone H3 and suppresses PPARα-regulated gene transcription and tumour growth.

Authors:  Zheng Wang; Min Li; Hongfei Jiang; Shudi Luo; Fei Shao; Yan Xia; Mengke Yang; Xiangle Ren; Tong Liu; Meisi Yan; Xu Qian; Haiyan He; Dong Guo; Yuran Duan; Ke Wu; Lei Wang; Guimei Ji; Yuli Shen; Lin Li; Peixiang Zheng; Bofei Dong; Jing Fang; Min Zheng; Tingbo Liang; Haitao Li; Rilei Yu; Daqian Xu; Zhimin Lu
Journal:  Nat Cell Biol       Date:  2022-10-20       Impact factor: 28.213

3.  Choline Kinase Alpha2 Promotes Lipid Droplet Lipolysis in Non-Small-Cell Lung Carcinoma.

Authors:  Rongxuan Zhu; Yannan Yang; Fei Shao; Juhong Wang; Yibo Gao; Jie He; Zhimin Lu
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

Review 4.  Metabolic reprogramming and epigenetic modifications on the path to cancer.

Authors:  Linchong Sun; Huafeng Zhang; Ping Gao
Journal:  Protein Cell       Date:  2021-05-29       Impact factor: 15.328

5.  Elevated nuclear localization of glycolytic enzyme TPI1 promotes lung adenocarcinoma and enhances chemoresistance.

Authors:  Peng Liu; Si-Jia Sun; Ying-Jie Ai; Xu Feng; Yi-Min Zheng; Yun Gao; Jin-Ye Zhang; Lei Zhang; Yi-Ping Sun; Yue Xiong; Miao Lin; Hai-Xin Yuan
Journal:  Cell Death Dis       Date:  2022-03-04       Impact factor: 8.469

6.  A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells.

Authors:  Qingxia Ma; Zhaoyuan Meng; Ying Meng; Rui Liu; Zhimin Lu
Journal:  Cancer Commun (Lond)       Date:  2021-08-27

Review 7.  The Interplay Between TGF-β Signaling and Cell Metabolism.

Authors:  Huidong Liu; Ye-Guang Chen
Journal:  Front Cell Dev Biol       Date:  2022-03-09

8.  Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer.

Authors:  Xi Liu; Shuangjie Liu; Chiyuan Piao; Zhe Zhang; Xiaotong Zhang; Yuanjun Jiang; Chuize Kong
Journal:  Cancer Sci       Date:  2021-10-24       Impact factor: 6.716

Review 9.  Metabolic landscapes in sarcomas.

Authors:  Richard Miallot; Franck Galland; Virginie Millet; Jean-Yves Blay; Philippe Naquet
Journal:  J Hematol Oncol       Date:  2021-07-22       Impact factor: 17.388

Review 10.  Cancer metabolism: looking forward.

Authors:  Inmaculada Martínez-Reyes; Navdeep S Chandel
Journal:  Nat Rev Cancer       Date:  2021-07-16       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.